ADLM 2025 ACCENT & CME Credit Information

Access the ADLM 2025 evaluation site below to claim ACCENT and CME credits by October 31, 2025.

Claim ACCENT & CME Credit

ADLM 2025 (formerly AACC Annual Scientific Meeting & Clinical Lab Expo) brings together the global laboratory medicine community and provides the latest education to meet the changing needs of laboratory professionals. This conference provides attendees opportunities to connect with global leaders, learn about cutting edge technology, and stay up to date on best practices and advances in laboratory medicine. Individuals may attend ADLM 2025 educational sessions from Sunday, July 27 - Thursday, July 31, at the McCormick Place Convention Center in Chicago, IL. Details on certificates of participation and claiming CE and/or CME credits are below. Claims must be made by October 31, 2025.

For questions regarding continuing education, please email [email protected].

Full Faculty Disclosure Listing

Accreditation Statements

(As of April 23, 2025; total credits may be subject to change based on session availability.)

ADLM offers ACCENT credit to laboratory professionals to document their continuing education and meet requirements for licensure or certification. ADLM is an approved provider of continuing education for clinical laboratory professionals, and is accepted by many licensure/certificate boards and US states (including California and Florida). California clinical laboratory professionals requesting ACCENT credit must provide their license number for credit to be reported to the California Department of Public Health Laboratory Field Services. Florida clinical laboratory professionals requesting ACCENT credit must provide their license number for credit to be reported to CE Broker. This educational activity is designated for a maximum of 28.0 ACCENT credits. Learners should claim only the credit commensurate with the extent of their participation in the activity. For information about ACCENT credit per session, visit the online session search or mobile app, which will be available for download later this summer.

ADLM is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. This educational activity is designated for a maximum of 22.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For information about AMA PRA Category 1 Credits™ per session, visit the online session search or mobile app, which will be available for download later this summer.

Learning Objectives

At the end of this activity, participants will be able to:

1. Discuss state-of-the-art research and technologies in laboratory medicine.
2. Apply updated knowledge of laboratory protocols, practice guidelines, and regulatory requirements in laboratory medicine.
3. Incorporate laboratory management strategies that ensure staff competency, enhance workflows, and support accurate and effective testing to improve treatment decisions and patient outcomes.
4. Implement up-to-date laboratory testing methods, technologies, and data-driven approaches in preanalytical, analytical, and postanalytical phases of sample handling.
5. Select appropriate testing methods and advise clinicians on appropriate testing that takes benefits, limitations, and patient outcomes into consideration.
6. Facilitate interprofessional communication with the broader healthcare team to demonstrate the value of laboratory medicine and its role in treatment decisions and patient outcomes.

Target Audience

ADLM 2025 is a global scientific/medical conference designed for clinical laboratory professionals, physicians, research scientists, and other professionals from around the world focused on laboratory medicine, clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas progressing laboratory science and medicine.

Statement of Independence

As a provider of continuing education, ADLM has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of ADLM’s Annual Meeting Organizing Committee (AMOC).

Disclosure Policy

The faculty, planning committee members, and staff who are in a position to control the content of this activity are required to disclose to ADLM and to learners any financial relationship(s) of the individual that have occurred within the last 24 months with any ACCME-defined ineligible companies. An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are defined by remuneration in any amount from the ineligible companies in the form of honoraria; consulting fees; grants or research support; payments for participation on advisory boards, boards of directors, committees, or speakers’ bureaus; stocks, bonds, other ownership interests; salary; intellectual property or royalties; or other financial benefits. The intent of this disclosure is not to prevent planners with financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. ADLM has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable. All ADLM 2025 faculty disclosures can be found here.

The following activity planners reported the following financial relationship(s):

2025 Annual Meeting Organizing Committee

• Steven Cotten
  Consultancy, Advisory Boards, etc.: Deconda LLC
• Leslie Donato
  Honoraria/Expenses: Helena Laboratories; Novartis
  Grant Support: Novartis; Sphingotec
• Anna Fuezery
  Honoraria/Expenses: Nova Biomedical
• Uttam Garg
  Disclosed no relevant conflicts of interest.
• Stephen Master
  Consultancy, Advisory Boards, etc.: Indigo BioAutomation
  Patents or royalties: US Patent US11473131B2, “Methods for detecting genomic DNA methylation” (University of Pennsylvania)
• Gwendolyn McMillin
  Consultancy, Advisory Boards, etc.: Concert Genetics
• Robert Nerenz
  Honoraria/Expenses: Abbott Diagnostics
  Grant Support: Abbott Diagnostics
  Consultancy, Advisory Boards, etc.: Porex
• Curtis Oleschuk
  Disclosed no relevant conflicts of interest.
• Kacy Peterson
  Disclosed no relevant conflicts of interest.
• Heather Stieglitz
  Disclosed no relevant conflicts of interest.
• Stefani Thomas
  Disclosed no relevant conflicts of interest.
• Sarah Wheeler
  Honoraria/Expenses: Siemens Healthineers; Roche; Abbott
  Grant Support: Siemens Healthineers

The following ADLM accreditation oversight committees reviewed the activity to ensure compliance with applicable accreditation standards and requirements for the respective accrediting bodies. The members of ADLM accreditation oversight committees reported the following financial relationship(s):

CME Subcommittee

• Baha Adam
  Disclosed no relevant conflicts of interest.
• Melissa Ulas
  Consultancy, Advisory Boards: Accurant Biotech Inc, siParadigm Diagnostics LLC, Lighthouse Lab Services
  Honoraria/Expenses: Helena Laboratories, Sysmex
• Clayton Wilburn
  Disclosed no relevant conflicts of interest.
• William Winter
  Consultancy, Advisory Boards: Becton-Dickinson (ended Nov. 2024), Bio-Rad
• Gabrielle Winston-McPherson
  Disclosed no relevant conflicts of interest.

ACCENT Review Board

• Shu-Ling Fan
  Disclosed no relevant conflicts of interest.
• Stacy Kenyon
  Salary: Labcorp (ended Nov. 2022)
  Stocks/Bonds: Labcorp
• Edward Leung
  Disclosed no relevant conflicts of interest.
• Jieli Shirley Li
  Disclosed no relevant conflicts of interest.
• Matthew Shashack
  Disclosed no relevant conflicts of interest.
• Zahra Shajani-Yi
  Salary: Labcorp
  Stocks/Bonds: Labcorp

A summary of all faculty disclosures is available on the following faculty disclosures listing, on the online session search, and in the mobile app, which will be available for download later this summer. All faculty will also display their disclosure information at the beginning of each session, verbally and/or on their presentation slides.

All ADLM staff involved in the planning of this activity reported no financial relationships.

Content Validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; and/or all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Disclaimers

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of ADLM.

Use of Professional Judgment

The educational content in this activity relates to basic principles of clinical laboratory medicine and does not substitute for individual assessment based on the health care professional’s examination of the patient, laboratory data, and other factors unique to the patient. Standards in medicine change as new data becomes available.

Drugs and Dosages

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

Policy on Unlabeled/Off-Label Use

The association has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The association requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

Privacy and Confidentiality Statement

The association will record learner’s personal information as provided on continuing education evaluations to allow for issuance and tracking of CE certificates. The association may also track aggregate responses to questions in activities and evaluations and use this data to inform the ongoing evaluation and improvement of its continuing education program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

Acknowledgement of Commercial Support

This activity is not supported by educational grant(s) or other funds from any commercial supporter(s).

Eligibility to Earn ACCENT and CME Credit

You must be registered for ADLM 2025* to be eligible to earn continuing education credit (ACCENT or AMA PRA Category 1 Credit™) for the following sessions of ADLM 2025: ADLM University Courses, Plenary, Meet-the-Expert, Scientific Sessions, and Roundtables. Continuing education certificates are provided to registered participants based on completion of the activity, in its entirety, including the activity evaluation.

* Individuals registered as a Guest/Spouse, Exhibitor, or Expo Only attendee are not eligible to earn credit for these sessions.

System Requirements

To claim continuing education credit, participants must have access to a computer or mobile device with an internet connection and use an up-to-date version of any major web browser, such as Microsoft Edge, Firefox, Safari, or Google Chrome. Internet Explorer is no longer supported.

California and Florida Licensed Laboratory Professionals Claiming ACCENT Credit

California licensees deadline to claim is October 31, 2025.

To claim ACCENT credit, California clinical laboratory professionals must provide a valid 6-digit California license number in the evaluation site (see below), including 3-letter license type code. You must complete all session evaluations and print your certificate by October 31, 2025. Important: Some sessions are marked as ineligible for California licensees. Submitting for credit on these may result in reporting errors. Credit cannot be reported if all requirements are not met.

Florida licensees deadline to claim is October 31, 2025.

To claim ACCENT credit, Florida clinical laboratory professionals must provide a valid Florida license number in the evaluation site (see below), including 2-letter license type code. You must complete all session evaluations and print your certificate by October 31, 2025. Credit cannot be reported if all requirements are not met.

How to Claim ACCENT and CME Credit & Print Your Certificate of Attendance

1. Access the evaluation site starting July 27 by:
   • Visiting the ADLM 2025 Evaluation Portal; or
   • Clicking the CE/CME tile on the meeting mobile app.
2. Log in using your LAST NAME and ADLM ID or BADGE number.
3. To claim ACCENT or CME:
   • Navigate to the appropriate tab.
   • Complete evaluations for each session you attended.
   • Manually add sessions by clicking "ADD SESSION" and using the search.
   • Ticketed sessions are automatically added.
   • If a ticketed session is missing, contact [email protected].
   • You may not claim credit for overlapping sessions. No exceptions.
   • Complete the overall meeting evaluation.
   • Print or save to PDF your certificate once complete.
4. To print a certificate of attendance:
   • Complete the overall meeting evaluation.
   • Print or save to PDF your certificate once complete.
5. Credits may be claimed online starting July 27, 2025.
6. Deadline to claim ACCENT or CME credit is October 31, 2025.

RELEASE DATE: July 27, 2025
EXPIRATION DATE: October 31, 2025 (date after which continuing education credit cannot be claimed for this activity).

For missing ticketed events, email [email protected].

For questions regarding continuing education, email [email protected].